PPIs Get AHRQ Stamp Of Approval Vs. Surgery; Generics Could Be Big Winners

The Agency for Healthcare Research & Quality's study on the effectiveness of proton pump inhibitors could lead to more difficulties for brand companies in seeking formulary placement